Ubat kanser Avastin atau Bevacizumab menyebabkan
pesakit kanser mati lebih cepat
Avastin boosts death risk in cancer
patients
|
||
Source: The Star, February 3, 2011
|
||
Washington
(U.S.A) - The cancer drug Avastin, also
known as bevacizumab, is linked to a higher risk of death when
combined with chemotherapy, a study published in the Journal of the
American Medical Association said. The drug had been
previously found to raise the risk of blood clots in the legs and lungs by 33
per cent. Last December, the US Food and Drug Administration said it
was neither safe nor effective against breast cancer.
Bevacizumab,
marketed as Avastin by the Swiss drug giant Roche, was approved for use in
combination with chemotherapy for treating colorectal cancer, non-small cell
lung cancer and renal cell carcinoma.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.